For the quarter ending 2025-09-30, QURE had $343,277K increase in cash & cash equivalents over the period. -$16,333K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -80,529 | -81,356 |
| Depreciation and amortization | 3,632 | 8,157 |
| Amortization of discount on investment securities | -1,928 | -4,163 |
| Share-based compensation expense | 3,522 | 9,494 |
| Royalty financing agreement interest expense, net of interest paid | 8,583 | 20,626 |
| Deferred tax expense | 1,058 | 921 |
| Changes in fair value of contingent consideration | 1,823 | 3,470 |
| Changes in fair value of liability related to pre-funded warrants | 5,722 | - |
| Unrealized foreign exchange gains, net | -629 | 25,163 |
| Other items, net | -638 | 3,651 |
| Accounts receivable, prepaid expenses, and other current assets and receivables | -9,641 | 6,761 |
| Accounts payable | 649 | -2,297 |
| Income tax payable | 7,568 | - |
| Accrued expenses, other liabilities, and operating leases | 22,593 | -3,272 |
| Net cash used in operating activities | -16,399 | -83,995 |
| Proceeds on maturity of debt securities | 123,432 | 213,763 |
| Investment in debt securities | 96,919 | 120,205 |
| Purchases of property, plant, and equipment | -66 | 386 |
| Net cash generated from investing activities | 26,579 | 93,172 |
| Proceeds from follow-on public offerings of ordinary shares, net of issuance costs | 300,226 | 80,511 |
| Proceeds from issuance of pre-funded warrants, net of issuance costs | 23,499 | - |
| Proceeds from issuance of ordinary shares related to employee stock options and purchase plans | 8,510 | 203 |
| Net cash generated from / (used in) financing activities | 332,235 | 80,714 |
| Currency effect on cash, cash equivalents and restricted cash | 862 | 5,052 |
| Net increase in cash, cash equivalents and restricted cash | 343,277 | 94,943 |
| Cash and cash equivalents at beginning of period | 160,329 | - |
| Cash and cash equivalents at end of period | 598,549 | - |
uniQure N.V. (QURE)
uniQure N.V. (QURE)